Regeneron turns to IT to accelerate drug discovery
CIO Business Intelligence
NOVEMBER 4, 2022
Then the data is consumed by SaaS-based computational tools, but it still sits within our organization and sits within the controls of our cloud-based solutions.” Much of Regeneron’s data, of course, is confidential. For that reason, many of its data tools — and even its data lake — were built in-house using AWS. “We
Let's personalize your content